CutisPharma Secures New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    841 Woburn Street Wilmington, MA 01887 USA
  • Company Description
    CutisPharma is the industry leader in bringing innovation to the pharmaceutical compounding market. We aim to achieve the transformation of prescription compounding with high-quality products manufactured under strict compliance standards that increase the accuracy, quality, and efficiency of compounded prescriptions dispensed to patients.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy